INVERNIZZI PIETRO

Role: 
Full professor
Academic disciplines: 
GASTROENTEROLOGY (MED/12)
Telephone: 
0264488139
0264488089
Room: 
U08, Piano: P03, Stanza: 3019
Via Cadore 48 - 20900 MONZA
U08, Piano: P03, Stanza: 3020
Via Cadore 48 - 20900 MONZA

Publications

  • Gerussi, A., Restelli, U., Croce, D., Bonfanti, M., Invernizzi, P., & Carbone, M. (2021). Cost of illness of Primary Biliary Cholangitis - a population-based study. DIGESTIVE AND LIVER DISEASE, 53(9), 1167-1170 [10.1016/j.dld.2020.07.029].
  • Gerussi, A., Bernasconi, D., O'Donnell, S., Lammers, W., Buuren, H., Hirschfield, G., et al. (2021). Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 19(8 (August 2021)), 1688-1697 [10.1016/j.cgh.2020.08.006].
  • Gerussi, A., Natalini, A., Antonangeli, F., Mancuso, C., Agostinetto, E., Barisani, D., et al. (2021). Immune-mediated drug-induced liver injury: Immunogenetics and experimental models. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 22(9) [10.3390/ijms22094557].
  • Nevi, L., Di Matteo, S., Carpino, G., Zizzari, I., Safarikia, S., Ambrosino, V., et al. (2021). DCLK1, a putative novel stem cell marker in human cholangiocarcinoma. HEPATOLOGY, 73(1), 144-159 [10.1002/hep.31571].
  • Carbone, M., Ronca, V., & Invernizzi, P. (2021). Reply to: “A spotlight on natural killer cells in primary biliary cholangitis”. JOURNAL OF HEPATOLOGY, 74(1 (January 2021)), 255-256.